Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
About this Journal
Privacy Statement
Open access policy
Cost of publication
Guides for authors
Current
Archives
Editorial Board
Submissions
Archive 2018-2006
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 48 No. 2 (2026): Experimental Oncology
Vol. 48 No. 2 (2026): Experimental Oncology
DOI:
https://doi.org/10.15407/exp-oncology.2026.02
Published:
21.08.2026
Reviews
THERAPEUTIC ROLE OF siRNA IN GASTRIC CANCER: GENE SILENCING MECHANISMS AND NANOCARRIER-BASED DELIVERY STRATEGIES
Gheysar Seifollahnezhad , Berrin Erdağ
81-97
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.081
MINIMAL RESIDUAL DISEASE ASSESSMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA: METHODS FOR DETECTION AND QUANTIFICATION
Sara Addakiri, Hanaa Bencharef, Asmaa Harrach, Samiha Jaddaoui, Khadija Ait-Ichou, Bouchra Oukkache
98-107
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.098
MINIMAL RESPIRATORY MOTION OF THE BREAST IN FREE BREATHING: A 4D CT NARRATIVE VIDEO REVIEW
V. Vinh-Hung, O. Gorobets, W. Kao, T. Gevaert, G. Storme, G. D’Amato, N.P. Nguyen, M. De Ridder
108-119
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.108
Original contributions
SULFORAPHANE SUPPRESSES HEPATOCELLULAR CARCINOMA IN MICE VIA ACTIVATING p53, MITIGATING OXIDATIVE STRESS, AND INHIBITING ANGIOGENESIS
Kholoud A. Omran, Yomna I. Mahmoud, Asmaa A. Mahmoud, Nagui H. Fares
120-132
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.120
STUDY OF PREDICTIVE VALUE OF RAD51 EXPRESSION FOR THE EFFECTIVENESS OF PLATINUM-BASED THERAPY OF HIGH-GRADE SEROUS OVARIAN CARCINOMA
P. Gordiichuk, M. Doronina, O. Ponomarova, M. Gordiichuk, D. Shapochka, D. Melnyk, A. Tereshchenko
133-138
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.133
EXPRESSION PATTERNS AND CLINICAL SIGNIFICANCE OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2/neu IN GALLBLADDER CANCER
Deepti Mishra, Akhilesh Krishna, Priyanka Sameer, Shreshtha Ghosh, Durgesh Kumar, Ankur Verma
139-145
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.139
SURVIVAL PREDICTORS IN CANCER PATIENTS WITH BONE METASTASIS: RETROSPECTIVE COHORT SINGLE-CENTER STUDY
M. Vorobchuk, A. Burlaka, A. Diedkov
146-151
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.146
SMOKING, ENVIRONMENTAL EXPOSURES, AND CHRONIC LUNG DISEASE AS KEY RISK FACTORS FOR LUNG CANCER IN NORTH SUMATRA
Putri Aulia Anwar, Noni Novisari Soeroso, Setia Putra Tarigan, Putri Chairani Eyanoer
152-160
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.152
DYNAMIC ANDROGEN RESPONSE INDEX AND ITS ASSOCIATION WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT ANDROGEN DEPRIVATION THERAPY
Ye. Afanasiev, S. Vozianov, R. Danylets, V. Grygorenko, O. Shulyak, M. Sosnin, I. Kholokharenko
161-171
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.161
Case report
PHENOTYPIC SHIFT OF ADENOCARCINOMA TO SQUAMOUS CELL CARCINOMA OF RECTUM AFTER NEOADJUVANT CHEMORADIOTHERAPY WITH DETECTION OF HPV16: A CLINICAL CASE
O. Kovalyov, S. Zavhorodniy, O. Tolok, A. Anenko, M. Kubrak, M. Danilyuk, K. Kovalyov
172-180
PDF
DOI:
https://doi.org/10.15407/exp-oncology.2026.02.172
Language
Українська
English
Make a Submission
Make a Submission